5-FU, Irinotecan, Nab-Paclitaxel in Gastrointestinal Cancers-Response

Clin Cancer Res. 2020 Jul 15;26(14):3890. doi: 10.1158/1078-0432.CCR-20-1219.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Albumins
  • Fluorouracil* / adverse effects
  • Gastrointestinal Neoplasms* / drug therapy
  • Genotype
  • Humans
  • Irinotecan
  • Leucovorin
  • Paclitaxel / adverse effects

Substances

  • 130-nm albumin-bound paclitaxel
  • Albumins
  • Irinotecan
  • Paclitaxel
  • Leucovorin
  • Fluorouracil